BaseLaunch can take full advantage of the potential of Basel’s life sciences ecosystem

The new accelerator for healthcare ventures, BaseLaunch, wants to link the best start-ups to the Basel region – and in doing so, provide impulses for…
Clozel’s Actelion R&D spinout gets a name
→ Jean-Paul Clozel has a name for his biotech spinout. Once J&J’s $30 billion deal to acquire Actelion goes through, the R&D side of the…
clement15.03.2017
Non-dilutive funding: Event gives an overview of funding sources

Innovation is the key to success for SMEs and start-ups. But they need money for this. One way to develop and maintain innovative business areas…
clement15.03.2017
BaseLaunch wants to bring the best healthcare start-ups to Basel

“If we invest billions in university research, then this remains an abortive effort if we do not make sure at the same time that these…
clement15.03.2017
Genentech to start new trial for Alzheimer’s drug

Genentech, an American subsidiary of the Basel-based pharmaceutical company Roche, will start a second Phase 3 clinical trial for its Alzheimer’s therapy crenezumab.
clement01.03.2017
BioMedPartners announces first closing of new fund

The Basel-based venture capital firm BioMedPartners has raised CHF 75 million in the first closing of their fund BioMedInvest III, a healthcare venture capital fund…
clement17.02.2017
BaselArea.swiss and Swiss HLG workshop “Valuation of Early Stage Biotech Companies – Net Present Value versus VC approach”
The risk adjusted, net present value (rNPV) method is the standard valuation method used within pharma and biotech companies when valuing assets beyond discovery stage.…
clement15.02.2017
UPDATED: Patent board tells CRISPR scientists to back off from a nasty fight over gene editing tech

The latest round in the title patent fight between The Broad and UC Berkelely over CRISPR/Cas9 tech goes to … Editas Medicine. The US Patent…
clement15.02.2017
Basel companies lead in R&D investments

The two Basel-based companies Novartis and Roche invest more in research and development than all other international pharmaceutical companies, according to the 2016 EU Industrial…
clement15.02.2017